Abstract
<h3>Background</h3> Human papillomavirus (HPV) infection causes at least 650,000 anogenital and oropharyngeal cancers (OPC) worldwide annually. Despite the viral immunological target, immune checkpoint inhibitors produce responses only in a minority...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have